Health Port further powers Jinwan's bio-med industry

Zhuhai International Health Port opened on July 26 with 10 enterprises already in house. A large number of medically related businesses is anticipated at the 1.8-billion yuan ($282-million) comprehensive biomedicine industrial park.

The park is located strategically at the intersection of Airport Expressway and West Airport Road in Sanzao. It is the core part of Jinwan District's emerging bio-medicine cluster.

Covering 16.7 hectares (41.3 acres), the comprehensive Health Port will have total floorage of 27.8 hectares (68.7 acres). It will handle biomedicine, R&D, industrial transformation, financial investment, sales, and commercial logistics in an industry-university-research format.

The multi-service facility will have functional zones for administrative services, living facilities, biological incubation R&D, manufacturing, and medical logistics.

An all-round public technical service system will comprise an animal medical laboratory, generic drug-quality research, and biomedicine inspection and detection centers. There will also be a Guangdong provincial center for food-and-drug review and authentication, good manufacturing practice (GMP) education center, and a research institute for innovative molecular imaging technologies.

First-group companies located or having projects in the Health Port include Beijing Digital Precision Medicine Technology, a provider of high-end medical devices and innovative technology; Zhuhai Trinomab Biotechnology, a high-tech company dedicated to R&D of immunotherapy and antibody compounds; and the mRNA project of Livzon Pharmaceutical Group, which relocated to Jinwan Livzon Industrial Park in 2016.

The project is expected to become renowned for innovative medicine, high-performance medical equipment, and intelligent medical diagnosis, according to a manager.